730948-07-9Relevant academic research and scientific papers
Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists
Gianella-Borradori, Matteo,Christou, Ivy,Bataille, Carole J.R.,Cross, Rebecca L.,Wynne, Graham M.,Greaves, David R.,Russell, Angela J.
, p. 241 - 263 (2015/01/16)
The cannabinoid receptor 2 (CB2R) has been linked with the regulation of inflammation, and selective receptor activation has been proposed as a target for the treatment of a range of inflammatory diseases such as atherosclerosis and arthritis.
Cannabinoid-2-Receptor Agonists
-
Paragraph 0588-0592, (2015/01/07)
The present invention relates to cannabinoid-2-receptor (CB2R) agonist compounds. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them and to their use as therapeutic agents
CANNABINOID-2-RECEPTOR AGONISTS
-
Paragraph 00353-00356, (2013/04/10)
The present invention relates to cannabinnoid-2-receptor (CB2R) agonist compounds. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them and to their use as therapeutic agents for the treatment and/or prevention of diseases or conditions in which CB2R stimulation is beneficial (especially inflammatory conditions).
